What is Regenxbio's stock issuance proceeds?

Regenxbio (RGNX) reported stock issuance proceeds of $146K in Q1 2026.

How has Regenxbio's stock issuance proceeds changed year-over-year?

Regenxbio's stock issuance proceeds decreased by 2.7% year-over-year, from $150K to $146K.

What is the long-term trend for Regenxbio's stock issuance proceeds?

Over 4 years (2021 to 2025), Regenxbio's stock issuance proceeds has grown at a -47.8% compound annual growth rate (CAGR), from $4.28M to $318K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Regenxbio RGNX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron PharmaceuticalsREGN

$163.1M+169%

Sarepta Therapeutics, Inc.SRPT

$241K-98.5%

EyePoint, Inc. EYPT

$166.79M+10.1%

4D Molecular TherapeuticsFDMT

$3.11M+120%

Solid Biosciences Inc.SLDB

$18K—

Immix Biopharma, Inc.IMMX

$33.53K—

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's stock issuance proceeds?: Regenxbio (RGNX) reported stock issuance proceeds of $146K in Q1 2026.
How has Regenxbio's stock issuance proceeds changed year-over-year?: Regenxbio's stock issuance proceeds decreased by 2.7% year-over-year, from $150K to $146K.
What is the long-term trend for Regenxbio's stock issuance proceeds?: Over 4 years (2021 to 2025), Regenxbio's stock issuance proceeds has grown at a -47.8% compound annual growth rate (CAGR), from $4.28M to $318K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.